SK285383B6 - Kompozície matrice s modifikovaným uvoľňovaním, sdlhodobým účinkom - Google Patents
Kompozície matrice s modifikovaným uvoľňovaním, sdlhodobým účinkom Download PDFInfo
- Publication number
- SK285383B6 SK285383B6 SK5022-2004A SK50222004A SK285383B6 SK 285383 B6 SK285383 B6 SK 285383B6 SK 50222004 A SK50222004 A SK 50222004A SK 285383 B6 SK285383 B6 SK 285383B6
- Authority
- SK
- Slovakia
- Prior art keywords
- weight
- pharmaceutically acceptable
- zidovudine
- lamivudine
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/IN2002/000110 WO2003090762A1 (en) | 2002-04-23 | 2002-04-23 | Long acting compositions comprising zidovudine and lamivudine |
Publications (2)
Publication Number | Publication Date |
---|---|
SK50222004A3 SK50222004A3 (sk) | 2005-05-05 |
SK285383B6 true SK285383B6 (sk) | 2006-12-07 |
Family
ID=29266770
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK5022-2004A SK285383B6 (sk) | 2002-04-23 | 2002-04-23 | Kompozície matrice s modifikovaným uvoľňovaním, sdlhodobým účinkom |
Country Status (12)
Country | Link |
---|---|
US (1) | US20050175694A1 (es) |
EP (1) | EP1501521B1 (es) |
AT (1) | ATE361080T1 (es) |
AU (1) | AU2002311622A1 (es) |
BR (1) | BR0215707A (es) |
CZ (1) | CZ20041117A3 (es) |
DE (1) | DE60219965T2 (es) |
ES (1) | ES2286258T3 (es) |
HU (1) | HUP0500217A2 (es) |
MX (1) | MXPA04010436A (es) |
SK (1) | SK285383B6 (es) |
WO (1) | WO2003090762A1 (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2006325404B2 (en) * | 2005-12-14 | 2012-03-01 | Cipla Limited | Pharmaceutical combination comprising nucleotide and nucleoside reverse transcriptase inhibitors (such as tenofovir and lamivudine) in different parts of the dosage unit |
WO2009129094A2 (en) * | 2008-04-15 | 2009-10-22 | Mallinckrodt Inc. | Compositions containing antiviral compounds and methods of using the same |
CN102488671A (zh) * | 2011-12-15 | 2012-06-13 | 合肥华方医药科技有限公司 | 一种拉米夫定控释片制剂及其制备方法 |
SG11202110236QA (en) * | 2019-04-05 | 2021-10-28 | Gedea Biotech Ab | Vaginal tablet formulation |
CN115813970B (zh) * | 2022-11-25 | 2024-05-07 | 深圳福山生物科技有限公司 | 一种稳定释放的营养靶向组合物及其用途 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4036228A (en) * | 1975-09-11 | 1977-07-19 | Alza Corporation | Osmotic dispenser with gas generating means |
WO1994003471A1 (en) * | 1992-08-04 | 1994-02-17 | Verex Laboratories, Inc. | Controlled release pharmaceutical formulations of 3'-azido-3'-deoxythymidine and methods of use |
US6113920A (en) * | 1996-10-31 | 2000-09-05 | Glaxo Wellcome Inc. | Pharmaceutical compositions |
GB9622681D0 (en) * | 1996-10-31 | 1997-01-08 | Glaxo Group Ltd | Pharmaceutical compositions |
GB9809213D0 (en) * | 1998-04-29 | 1998-07-01 | Glaxo Group Ltd | Pharmaceutical compositions |
CZ2001901A3 (cs) * | 1998-09-14 | 2001-08-15 | Ranbaxy Laboratories Limited | Farmaceutická kompozice představující systém řízeného dodávání léku pro orální podání, poskytující časovou a místní kontrolu |
-
2002
- 2002-04-23 CZ CZ20041117A patent/CZ20041117A3/cs unknown
- 2002-04-23 DE DE60219965T patent/DE60219965T2/de not_active Expired - Fee Related
- 2002-04-23 ES ES02738611T patent/ES2286258T3/es not_active Expired - Lifetime
- 2002-04-23 HU HU0500217A patent/HUP0500217A2/hu unknown
- 2002-04-23 WO PCT/IN2002/000110 patent/WO2003090762A1/en active IP Right Grant
- 2002-04-23 SK SK5022-2004A patent/SK285383B6/sk not_active IP Right Cessation
- 2002-04-23 AT AT02738611T patent/ATE361080T1/de not_active IP Right Cessation
- 2002-04-23 EP EP02738611A patent/EP1501521B1/en not_active Expired - Lifetime
- 2002-04-23 AU AU2002311622A patent/AU2002311622A1/en not_active Abandoned
- 2002-04-23 US US10/512,464 patent/US20050175694A1/en not_active Abandoned
- 2002-04-23 MX MXPA04010436A patent/MXPA04010436A/es active IP Right Grant
- 2002-04-23 BR BR0215707-1A patent/BR0215707A/pt not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AU2002311622A1 (en) | 2003-11-10 |
ES2286258T3 (es) | 2007-12-01 |
US20050175694A1 (en) | 2005-08-11 |
BR0215707A (pt) | 2005-05-03 |
MXPA04010436A (es) | 2005-05-27 |
EP1501521A1 (en) | 2005-02-02 |
EP1501521B1 (en) | 2007-05-02 |
CZ20041117A3 (cs) | 2005-04-13 |
DE60219965D1 (de) | 2007-06-14 |
WO2003090762A1 (en) | 2003-11-06 |
DE60219965T2 (de) | 2008-01-17 |
ATE361080T1 (de) | 2007-05-15 |
HUP0500217A2 (hu) | 2005-06-28 |
SK50222004A3 (sk) | 2005-05-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20090208579A1 (en) | Matrix Type Sustained-Release Preparation Containing Basic Drug or Salt Thereof, and Method for Manufacturing the Same | |
US20060193911A1 (en) | Controlled release venlafaxine formulations | |
NO319434B1 (no) | Farmasoytisk oral doseform av ranolazin-preparater med depotvirkning og en komprimert tablett. | |
JP2009137996A (ja) | ミコフェノール酸またはミコフェノール酸塩を含む医薬組成物 | |
KR20020075801A (ko) | 울혈성 심부전 치료의 부분적 지방산 산화 방지제 | |
JP2008069159A (ja) | 持続放出ラノラジン製剤 | |
JPH11505542A (ja) | 毎日一回投与するための、非晶質活性成分の一定のかつ制御された放出を行う三相型医薬製剤 | |
ZA200402369B (en) | Dosage form for treatment of diabetes mellitus | |
JP2008069159A5 (es) | ||
EP3131533A1 (en) | Oral dosage form of ketamine | |
AU2001240092A1 (en) | Sustained release ranolazine formulations | |
JP2011516613A (ja) | 好ましくはポサコナゾールおよびhpmcasを含む固体分散物中の経口用薬学的組成物 | |
US20070184110A1 (en) | Dipyridamole extended-release formulations and process for preparing same | |
KR20180083239A (ko) | 리마프로스트 또는 리마프로스트 알파엑스를 함유한 경구용 서방성 제제 조성물 | |
JP2010536798A (ja) | 難溶性薬物の生体利用率を制御するための方法及び組成物 | |
CA2835272A1 (en) | Pharmaceutical antiretroviral composition | |
US20070292505A1 (en) | Controlled release alfuzosin hydrochloride formulation | |
SK285383B6 (sk) | Kompozície matrice s modifikovaným uvoľňovaním, sdlhodobým účinkom | |
US20100285119A1 (en) | Multiparticulate Extended Release Pharmaceutical Composition Of Carbamazepine And Process For Manufacturing The Same | |
KR20190120093A (ko) | 레날리도마이드의 경구용 코팅 정제 조성물 | |
WO2019132839A1 (en) | Oral pharmaceutical compositions of dabigatran | |
EP1490034A1 (en) | Novel pharmaceutical compositions for antihistaminic-decongestant combination and method of making such compositions | |
WO2007143290A2 (en) | Delayed-release compositions of extended release forms of venlafaxine | |
ZA200408203B (en) | Long acting compositions comprising zidovudine and lamivudine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Patent lapsed due to non-payment of maintenance fees |
Effective date: 20090423 |